141 related articles for article (PubMed ID: 10545037)
1. Peripheral myelin modification in CMT1B correlates with MPZ gene mutations.
Lagueny A; Latour P; Vital A; Rajabally Y; Le Masson G; Ferrer X; Bernard I; Julien J; Vital C; Vandenberghe A
Neuromuscul Disord; 1999 Oct; 9(6-7):361-7. PubMed ID: 10545037
[TBL] [Abstract][Full Text] [Related]
2. Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease.
Roa BB; Warner LE; Garcia CA; Russo D; Lovelace R; Chance PF; Lupski JR
Hum Mutat; 1996; 7(1):36-45. PubMed ID: 8664899
[TBL] [Abstract][Full Text] [Related]
3. Focally folded myelin in Charcot-Marie-Tooth neuropathy type 1B with Ser49Leu in the myelin protein zero.
Fabrizi GM; Taioli F; Cavallaro T; Rigatelli F; Simonati A; Mariani G; Perrone P; Rizzuto N
Acta Neuropathol; 2000 Sep; 100(3):299-304. PubMed ID: 10965800
[TBL] [Abstract][Full Text] [Related]
4. Focally folded myelin in Charcot-Marie-Tooth type 1B disease is associated with Asn131Lys mutation in myelin protein zero gene: short report.
Kochański A; Drac H; Jedrzejowska H; Hausmanowa-Petrusewicz I
Eur J Neurol; 2003 Sep; 10(5):547-9. PubMed ID: 12940837
[TBL] [Abstract][Full Text] [Related]
5. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
6. Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder.
Rünker AE; Kobsar I; Fink T; Loers G; Tilling T; Putthoff P; Wessig C; Martini R; Schachner M
J Cell Biol; 2004 May; 165(4):565-73. PubMed ID: 15148307
[TBL] [Abstract][Full Text] [Related]
7. Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible "hotspot" on Thr124Met.
Senderek J; Hermanns B; Lehmann U; Bergmann C; Marx G; Kabus C; Timmerman V; Stoltenburg-Didinger G; Schröder JM
Brain Pathol; 2000 Apr; 10(2):235-48. PubMed ID: 10764043
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation of myelin protein zero associated with an axonal form of Charcot-Marie-Tooth disease.
Santoro L; Manganelli F; Di Maria E; Bordo D; Cassandrini D; Ajmar F; Mandich P; Bellone E
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):262-5. PubMed ID: 14742601
[TBL] [Abstract][Full Text] [Related]
9. A novel MPZ mutation in Charcot-Marie-Tooth disease type 1B with focally folded myelin and multiple entrapment neuropathies.
Iida M; Koike H; Ando T; Sugiura M; Yamamoto M; Tanaka F; Sobue G
Neuromuscul Disord; 2012 Feb; 22(2):166-9. PubMed ID: 21940171
[TBL] [Abstract][Full Text] [Related]
10. Screening of the myelin protein zero gene in patients with Charcot-Marie-Tooth disease.
Nowakowski A; Kochański A
Acta Biochim Pol; 2004; 51(1):273-80. PubMed ID: 15094849
[TBL] [Abstract][Full Text] [Related]
11. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration.
Li J; Bai Y; Ianakova E; Grandis M; Uchwat F; Trostinskaia A; Krajewski KM; Garbern J; Kupsky WJ; Shy ME
J Comp Neurol; 2006 Sep; 498(2):252-65. PubMed ID: 16856127
[TBL] [Abstract][Full Text] [Related]
12. Myelinated fibers in Charcot-Marie-Tooth disease type 1B with Arg98His mutation of Po protein.
Ohnishi A; Yamamoto T; Yamamori S; Sudo K; Fukushima Y; Ikeda M
J Neurol Sci; 1999 Dec; 171(2):97-109. PubMed ID: 10581375
[TBL] [Abstract][Full Text] [Related]
13. Myelin protein zero gene mutated in Charcot-Marie-tooth type 1B patients.
Su Y; Brooks DG; Li L; Lepercq J; Trofatter JA; Ravetch JV; Lebo RV
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10856-60. PubMed ID: 7504284
[TBL] [Abstract][Full Text] [Related]
14. De novo mutation (Arg98-->Cys) of the myelin P0 gene and uncompaction of the major dense line of the myelin sheath in a severe variant of Charcot-Marie-Tooth disease type 1B.
Komiyama A; Ohnishi A; Izawa K; Yamamori S; Ohashi H; Hasegawa O
J Neurol Sci; 1997 Jul; 149(1):103-9. PubMed ID: 9168174
[TBL] [Abstract][Full Text] [Related]
15. Myelin protein zero gene mutations in Taiwanese patients with Charcot-Marie-Tooth disease type 1.
Lee YC; Soong BW; Lin KP; Lee HY; Wu ZA; Kao KP
J Neurol Sci; 2004 Apr; 219(1-2):95-100. PubMed ID: 15050444
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis in Chariot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity.
Young P; Grote K; Kuhlenbäumer G; Debus O; Kurlemann H; Halfter H; Funke H; Ringelstein EB; Stögbauer F
J Neurol; 2001 May; 248(5):410-5. PubMed ID: 11437164
[TBL] [Abstract][Full Text] [Related]
17. Two novel mutations in the MPZ gene coding region in Charcot-Marie-Tooth type 1 patients of Turkish origin: S54P, [I30del; GVYI29ins].
Bissar-Tadmouri N; Gulsen-Parman Y; Latour P; Deymeer F; Serdaroglu P; Vandenberghe A; Battaloglu E
Hum Mutat; 1999 Nov; 14(5):449. PubMed ID: 10533074
[No Abstract] [Full Text] [Related]
18. Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation.
Eggers SD; Keswani SC; Melli G; Cornblath DR
Muscle Nerve; 2004 Jun; 29(6):867-9. PubMed ID: 15170620
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the same sequence of the myelin P0 gene causing two different phenotypes.
Schiavon F; Rampazzo A; Merlini L; Angelini C; Mostacciuolo ML
Hum Mutat; 1998; Suppl 1():S217-9. PubMed ID: 9452091
[No Abstract] [Full Text] [Related]
20. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
